P3 Health Partners (NASDAQ:PIII) Stock Price Up 11.9%

P3 Health Partners Inc. (NASDAQ:PIII - Get Free Report) shares rose 11.9% during mid-day trading on Wednesday . The stock traded as high as $0.58 and last traded at $0.58. Approximately 569,880 shares were traded during mid-day trading, an increase of 47% from the average daily volume of 386,497 shares. The stock had previously closed at $0.52.

Analyst Upgrades and Downgrades

• After Soaring 182% Is Time To Ring The Register In P3 Health?

A number of brokerages recently issued reports on PIII. BTIG Research downgraded shares of P3 Health Partners from a "buy" rating to a "neutral" rating in a report on Monday, April 1st. Lake Street Capital cut their price target on P3 Health Partners from $9.00 to $4.50 and set a "buy" rating for the company in a research note on Thursday, March 14th. Finally, William Blair reiterated an "outperform" rating on shares of P3 Health Partners in a research report on Monday, April 1st.

Check Out Our Latest Research Report on P3 Health Partners

P3 Health Partners Trading Up 11.9 %

The firm has a market capitalization of $183.95 million, a PE ratio of -0.99 and a beta of 1.22. The company's fifty day simple moving average is $0.62 and its 200-day simple moving average is $0.96. The company has a debt-to-equity ratio of 0.81, a current ratio of 0.55 and a quick ratio of 0.55.

P3 Health Partners (NASDAQ:PIII - Get Free Report) last issued its quarterly earnings results on Wednesday, May 8th. The company reported ($0.16) earnings per share for the quarter, beating analysts' consensus estimates of ($0.19) by $0.03. P3 Health Partners had a negative net margin of 4.97% and a negative return on equity of 79.03%. The firm had revenue of $388.49 million for the quarter, compared to analyst estimates of $352.00 million. As a group, sell-side analysts expect that P3 Health Partners Inc. will post -0.56 earnings per share for the current fiscal year.

Institutional Investors Weigh In On P3 Health Partners

Several institutional investors and hedge funds have recently added to or reduced their stakes in PIII. SlateStone Wealth LLC acquired a new stake in shares of P3 Health Partners in the fourth quarter valued at approximately $40,000. Welch Capital Partners LLC NY purchased a new position in shares of P3 Health Partners during the 4th quarter worth $42,000. PNC Financial Services Group Inc. purchased a new position in shares of P3 Health Partners during the 3rd quarter worth $101,000. Principal Financial Group Inc. boosted its position in shares of P3 Health Partners by 13.3% during the 3rd quarter. Principal Financial Group Inc. now owns 80,055 shares of the company's stock valued at $118,000 after acquiring an additional 9,400 shares during the last quarter. Finally, GSA Capital Partners LLP grew its holdings in shares of P3 Health Partners by 110.6% in the first quarter. GSA Capital Partners LLP now owns 565,522 shares of the company's stock valued at $582,000 after purchasing an additional 296,936 shares during the period. Institutional investors and hedge funds own 7.75% of the company's stock.

About P3 Health Partners

P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc was founded in 2020 and is based in Henderson, Nevada.

Featured Articles

• Five stocks we like better than P3 Health Partners
• What Is WallStreetBets and What Stocks Are They Targeting?
• Ollie’s Bargain Outlet Stock Won’t be a Bargain Much Longer
• Should You Add These Warren Buffett Stocks to Your Portfolio?
• CrowdStrike's Earnings: Consolidation and AI-Driven Growth
• What is the Shanghai Stock Exchange Composite Index?
• 3 Options Strategies to Protect Your Stocks in a Falling Market

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

→ [Urgent!] Generational Wealth Gameplan (From Crypto 101 Media) (Ad)

Should you invest $1,000 in P3 Health Partners right now?

Before you consider P3 Health Partners, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and P3 Health Partners wasn't on the list.

While P3 Health Partners currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here